Key Drugs, Mnemonics, Study Tips
RXPREP: KEY DRUGS, MNEMONICS, STUDY TIPS1 • HAZARDOUS DRUGS are: o Teratogenic o Carcinogenic o Genotoxic (damage the DNA and can cause cancer) o Have reproductive toxicity o Cause organ toxicity at low doses • Key hazardous drugs that require SPECIAL HANDLING to avoid toxicity to workers: o All pregnancy category X drugs, category D’s and a few C’s, and paroxetine, methotrexate, misoprostol, mifepristone, ribavirin o Antineoplastics (chemotherapeutics) o 5-alpha reductase inhibitors (dutasteride, finasteride) o Hormones (contraceptives, estradiol, testosterone) o Transplant drugs (MMF, tacrolimus, CYA, everolimus, sirolimus) o Others: colchicine, dronedarone, fluconazole, spironolactone, risperidone, raloxifene, rasagiline, ziprasidone • Key drugs most commonly associated with PHOTOSENSITIVITY: o Carbamazepine o Diuretics (thiazide and loop) o MTX o Oral and topical retinoids o Quinolones o St. John’s Wort o Sulfa antibiotics o Tacrolimus o Voriconazole o Others: amiodarone, antihistamines (1st generation), chloroquine, coal tar, fluorouracil, griseofulvin, NSAIDs, quinidine, tigecycline • Key drugs commonly associated with TTP: o Clopidogrel o Ticlopidine o Others: acyclovir, famciclovir, quinine, SMX, valacyclovir • CYP inducers o PS PORCS (big inducers) Phenytoin Smoking Phenobarbital Oxcarbazepine (and eslicarbazepine) Rifampin (and rifabutin, rifapentine) Carbamazepine (also an auto-inducer) St. John’s Wort • CYP inhibitors o G 3 PACMAN (big inhibitors) Grapefruit PIs protease inhibitors (ritonavir) Azole antifungals (fluconazole, itraconazole, ketoconazole, posaconazole, voriconazole, isavuconazonium) C: CYA, cimetidine, cobicistat Macrolides (clarithromycin, erythromycin, not azithromycin) Amiodarone (and dronedarone) Non-DHP CCBs (diltiazem and verapamil) • Key SEROTONERGIC drugs: o SSRIs o SNRIs o TCAs o MAOIs (plus linezolid and methylene blue) o Buspirone o Dextromethorphan o Fentanyl o Lithium o Methadone o Mirtazapine o St. John’s Wort o Tramadol o Trazodone o Others: cyclobenzaprine, lorcaserin, meperidine, 5HT3-RA, some triptans • Key drugs required/strongly recommended PGx testing: o Abacavir o Azathioprine o Carbamazepine o Cetuximab and panitumumab o Trastuzumab, ado-transtuzumab, lapatinib, pertuzumab o Others: allopurinol, capecitabine, fluorouracil, clopidogrel, codeine, phenytoin, fosphenytoin, warfarin • Key drugs - DO NOT put these drugs into PVC IV CONTAINERS o LATIN Lorazepam Amiodarone Tacrolimus Insulin NTG Others: cabazitaxel, carmustine, docetaxel, etoposide, ixabepilone, paclitaxel, sufentanil, temsirolimus, teniposide, thiopental • Key drugs - SALINE (no dextrose) o ACID APE Ampicillin Caspofungin Infliximab Daptomycin (Cubcin) Ampicillin/sulbactam Phenytoin Ertapenem (Invanz) Others: abatacept, azacitidine, belimumab, bevacizumab, idarucizumab, iron sucrose, sodium ferric gluconate complex, natalizumab, trastuzumab • Key drugs - DEXTROSE (no saline) o ABS Amphotericin B Bactrim Synercid (quinupristin/dalfopristin) Others: carfilzomib, MMF, pentamidine • Key drugs - common drugs with FILTER requirements o Most: 0.22-micron filter during administration* o Pushy guys in LA LA land Phenytoin Golimumab Lipids - 1.2 micron* Amphotericin B (lipid formulations)* Lorazepam Amiodarone • * larger pore size filter required; ampho prepare using a 5-micron filter Others: abatacept, abciximab, digoxin immune fab, infliximab, isavuconazonium, mannitol, thiotepa • Key drugs - DO NOT REFRIGERATE o Dear sweet pharmacist, marry me forever, eternally Dexmedetomidine SMX-TMP Phenytoin Metronidazole Moxifloxacin Furosemide Enoxaparin Others: acetaminophen, acyclovir, deferoxamine (Desferal), levetiracetam, pentamidine, valproate • Key drugs - PROTECT FROM LIGHT DURING ADMINISTRATION o Deliver every needed medication protected Doxycycline Epoprostenol Nitroprusside Micafungin Phytonadione Others: anthracyclines, dacarbazine, pentamidine • Key drugs - TERATOGENS o Acne: isotretinoin, topical retinoids (including tazarotene) o Abx: quinolones, tetracyclines o Anticoagulants: warfarin o HLD, HF, HTN: statins, RAAS inhibitors (ACEi, ARBs, aliskiren, sacubitril/valsartan) o Hormones: most, including estradiol, progesterone [megesterol (Megace)], raloxifene, Duavee, testosterone, contraceptives o Migraine: dihydroergotamine, ergotamine o Other important teratogens: hydroxyurea, lithium, MTX, misoprostol, paroxetine, ribavirin, thalidomide, topiramate, VPA, divalproex, weight loss drugs • Avoid in PEDIATRICS o Contraindicated Codeine age 12 y Tramadol age 12 y Promethazine age 2 y Ceftriaxone in neonates 1-28 d o Not generally recommended Quinolones Tetracyclines age 8 y OTC cough and cold preparations in age 6 y • Live vaccines o Injections MMR MMRV Varicella Zoster Yellow fever o Other routes Influenza intranasal Rotavirus Cholera Typhoid • Vaccines for specific conditions o Pregnancy Influenza vaccine Tdap x 1 with each pregnancy (optimal time between weeks 27 and 36) Live vaccines CI during pregnancy o Asplenia H. influenzae type B (HIB) Pneumococcal (Prevnar and Pneumovax 23) Meningococcal • Selected drugs that CAUSE KIDNEY DISEASE o Aminoglycosides o Amphotericin B o Cisplatin o Colistimethate o CYA o Loop diuretics o NSAIDs o Radio graphic contrast dye o Tacrolimus o Vancomycin • Study tip: CrCl vs GFR o CrCl Cockcroft-Gault equation CrCl = 140−patient age × 72 x SCr weight in kg (× 0.85 if female) For CrCl calculation, use ABW if patient is IBW, use IBW is normal weight (by • Select drugs that are CI IN KIDNEY IMPAIRMENT o CrCl 60 Nitrofurantoin o CrCl 50 Elvitegravir/cobicistat/ emtricitabine/TDF (Stribild) Voriconazole IV o CrCl 30 o GFR BMI) Dosing adjustments and CI’s are generally based on CrCl calculated with Cockcroft-Gault Avanafil Bisphosphonates Dabigatran Duloxetine CKD-EPI or MDRD equation Used for staging kidney disease and for dosing select drugs Not commonly calculated in the clinical setting, but may be reported by some laboratories For the exam, if GFR is not provided, CrCl provides a close estimate for doing and CI purposes • Select drugs that require OR
Información del documento
- Subido en
- 25 de septiembre de 2023
- Número de páginas
- 17
- Escrito en
- 2023/2024
- Tipo
- Examen
- Contiene
- Preguntas y respuestas